| Mr Seth Clayton Foote, PA STUDENT | |
|
3737 Southern Blvd, Kettering, OH 45429-1262 | |
| (937) 573-6682 | |
| Not Available |
| Full Name | Mr Seth Clayton Foote |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Experience | 7 Years |
| Location | 3737 Southern Blvd, Kettering, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821519687 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | STUDENT (* (Not Available)) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Premier Health Urgent Care, Inc. | 3870848088 | 34 |
News Archive
Drawing heavily upon nature for inspiration, a team of researchers has created a new artificial lens that is nearly identical to the natural lens of the human eye. This innovative lens, which is made up of thousands of nanoscale polymer layers, may one day provide a more natural performance in implantable lenses to replace damaged or diseased human eye lenses, as well as consumer vision products; it also may lead to superior ground and aerial surveillance technology.
Dicerna Pharmaceuticals, Inc., (Dicerna) a second generation RNA interference (RNAi) company developing novel therapeutics utilizing its proprietary Dicer Substrate Technology™ and Dicer Substrate siRNA (DsiRNA) molecules, and Kyowa Hakko Kirin Co., Ltd. (Kyowa Hakko Kirin), one of Japan's leading biopharmaceutical companies, announced today that the two companies have entered into a research collaboration and license agreement for the research, development and commercialization of drug delivery systems and DsiRNA pharmaceuticals for therapeutic targets in oncology.
Two Hershey, Pa., researchers were part of a team that has uncovered what may be an important genetic risk factor for amyotrophic lateral sclerosis (ALS).
Bewernick and colleagues administered DBS treatment in ten patients with severe long-term depression who had not responded to multiple other antidepressant treatments, including psychotherapy, drug treatments and electroconvulsive treatment. After one year of DBS, all patients showed some improvement, and half of them experienced significant improvement in their symptoms of depression, astonishing considering they had not responded to any prior antidepressant treatment. In addition, the patients showed reduced ratings of anxiety and had only minor side effects. Importantly, none of their overall brain functioning was impaired by the DBS treatment.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Seth Clayton Foote, PA STUDENT 36 Duerr Dr, West Milton, OH 45383-1401 Ph: (937) 573-6682 | Mr Seth Clayton Foote, PA STUDENT 3737 Southern Blvd, Kettering, OH 45429-1262 Ph: (937) 573-6682 |
News Archive
Drawing heavily upon nature for inspiration, a team of researchers has created a new artificial lens that is nearly identical to the natural lens of the human eye. This innovative lens, which is made up of thousands of nanoscale polymer layers, may one day provide a more natural performance in implantable lenses to replace damaged or diseased human eye lenses, as well as consumer vision products; it also may lead to superior ground and aerial surveillance technology.
Dicerna Pharmaceuticals, Inc., (Dicerna) a second generation RNA interference (RNAi) company developing novel therapeutics utilizing its proprietary Dicer Substrate Technology™ and Dicer Substrate siRNA (DsiRNA) molecules, and Kyowa Hakko Kirin Co., Ltd. (Kyowa Hakko Kirin), one of Japan's leading biopharmaceutical companies, announced today that the two companies have entered into a research collaboration and license agreement for the research, development and commercialization of drug delivery systems and DsiRNA pharmaceuticals for therapeutic targets in oncology.
Two Hershey, Pa., researchers were part of a team that has uncovered what may be an important genetic risk factor for amyotrophic lateral sclerosis (ALS).
Bewernick and colleagues administered DBS treatment in ten patients with severe long-term depression who had not responded to multiple other antidepressant treatments, including psychotherapy, drug treatments and electroconvulsive treatment. After one year of DBS, all patients showed some improvement, and half of them experienced significant improvement in their symptoms of depression, astonishing considering they had not responded to any prior antidepressant treatment. In addition, the patients showed reduced ratings of anxiety and had only minor side effects. Importantly, none of their overall brain functioning was impaired by the DBS treatment.
› Verified 6 days ago
Milena Menchaca, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 3535 Southern Blvd, Kettering, OH 45429 Phone: 937-395-8166 | |
Annabeth Pruett Barry, PA-C, MBA Physician Assistant Medicare: Medicare Enrolled Practice Location: 424 E Stroop Rd Unit B, Kettering, OH 45429 Phone: 937-562-2300 Fax: 937-562-2302 | |
Miss Kathryn Paige Combs, MPAS, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 3535 Southern Blvd, Kettering, OH 45429 Phone: 937-395-8166 | |
Michael D Kelley, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 3535 Southern Blvd, Kettering, OH 45429 Phone: 937-395-6665 Fax: 937-395-6668 | |
Marie Therese Mualla Oram, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 3700 Southern Blvd Ste 300, Kettering, OH 45429 Phone: 937-643-9299 Fax: 937-643-2343 | |
Lydia Nicole Little, PA-C Physician Assistant Medicare: May Accept Medicare Assignments Practice Location: 3535 Southern Blvd, Kettering, OH 45429 Phone: 937-643-9299 Fax: 937-643-2343 | |
Mr. David Evans, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 3533 Southern Blvd Ste 2250, Kettering, OH 45429 Phone: 937-534-0330 Fax: 937-522-8995 |